Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb;101(2):452-455.
doi: 10.1016/j.gie.2024.09.019. Epub 2024 Sep 18.

Effect of a novel artificial intelligence-based cecum recognition system on adenoma detection metrics in a screening colonoscopy setting

Affiliations
Free article

Effect of a novel artificial intelligence-based cecum recognition system on adenoma detection metrics in a screening colonoscopy setting

Wen-Feng Hsu et al. Gastrointest Endosc. 2025 Feb.
Free article

Abstract

Background and aims: Cecal intubation in colonoscopy relies on self-reporting. We developed an artificial intelligence-based cecum recognition system (AI-CRS) for post-hoc verification of cecal intubation and explored its impact on adenoma metrics.

Methods: Quality metrics, including cecal intubation rate (CIR), adenoma detection rate (ADR), and other ADR-related metrics, were compared both before (2015-2018) and after (2019-2022) the implementation of the AI-CRS.

Results: Although the CIR did not change significantly after the implementation of the AI-CRS, the ADR and advanced ADR significantly increased. Although the ADR significantly increased in all segments, the most significant increase in advanced ADR was observed in the proximal colon. Implementation of the AI-CRS was associated with a higher likelihood of detecting adenoma (adjusted odds ratio, 1.35; 95% confidence interval, 1.26-1.45) and advanced adenoma (adjusted odds ratio, 1.23; 95% confidence interval, 1.07-1.41), respectively.

Conclusions: Implementation of a post-hoc verification of cecal intubation using an AI-CRS significantly improved various adenoma metrics in screening colonoscopy.

PubMed Disclaimer

Conflict of interest statement

Disclosure The following author disclosed financial relationships: H-M. Chiu: Speaker for Olympus, Fujifilm, and Boston Scientific; research funding from Boston Scientific, Volition Rx, and Aether AI. All other authors disclosed no financial relationships. Research support for this study was provided in part to H-M. Chiu by the A1 Project of National Taiwan University Hospital (107-A142).

LinkOut - more resources